Concepedia

Niroo Gupta

NG

14

Publications

3.6K

Citations

13

H-Index

1975

Active since

Affiliations

Novartis (United States)(Current)

Creighton University

Peoria campus of the University of Illinois System

National Jewish Health

Novartis (Switzerland)

Niroo Gupta is an author at Novartis (United States) specializing in medicine, allergy, and asthma.

Top concepts

Publications per year

1975–2005

14

Publications

14

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

William W. Busse, Jonathan Corren, Bobby Q. Lanier et al. · Journal of Allergy and Clinical Immunology · 2001 · 1.3K citations · Full text

, , +9

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics

M. Solèr, Jonathan Matz, Robert G. Townley et al. · European Respiratory Journal · 2001 · 822 citations · Full text

Treatment of Childhood Asthma With Anti-Immunoglobulin E Antibody (Omalizumab)

Henry Milgrom, William Berger, Anjuli Nayak et al. · PEDIATRICS · 2001 · 513 citations

Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma

William E. Berger, Niroo Gupta, Margaret McAlary et al. · Annals of Allergy Asthma & Immunology · 2003 · 182 citations

, , +10

Omalizumab is effective in the long-term control of severe allergic asthma

Bobby Q. Lanier, Jonathan Corren, William R. Lumry et al. · Annals of Allergy Asthma & Immunology · 2003 · 181 citations

, , +10

Rows per page

1–5 of 14